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The first Virus Genomics and Evolution Conference
was held at the Wellcome Genome Campus in
Hinxton, UK, 8–10 June 2016.launched the meeting with tales of microbe-huntingIntroduction
In recognition of the increasingly important role that
genomics plays in virology and public health epidemi-
ology, the Wellcome Genome Campus hosted the inaug-
ural conference on Virus Genomics and Evolution in
June 2016. This multidisciplinary conference brought to-
gether public health researchers who are generating viral
genomic data from clinical samples and evolutionary bi-
ologists and bioinformaticians who are developing
methods to interrogate these data.
The meeting highlighted the broad temporal and
spatial scales over which viral genetic data are having an
impact, from understanding the trajectory of resistance
mutations during a single infection to understanding the
spatial expansion of viral lineages during large epi-
demics. Several talks featured memorable accounts of
the use of genomics in practical settings, from West
African field hospitals to European courtrooms. Interest-
ingly, there was little discussion of sequencing technolo-
gies themselves; rather the focus was on their practical,
actionable applications.
In this report, we highlight how genomics is being
used to explore viral origins and diversity and to under-
stand transmission and pathogenesis. Additionally, we
describe how real-time generation and analysis of viral* Correspondence: jennifer.gardy@bccdc.ca
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across many species and diseases, emphasizing that de-
tection of a virus genome in a sample is simply the first
step in the process of linking an agent to disease. Viral
discovery is fraught with false positives, and potential
associations should be explored via multiple avenues,
including serology and host response.
The scale of the viral discovery problem was
highlighted by Eddie Holmes (University of Sydney,
Australia), whose virus-hunting in diverse species—from
unusual arthropods to sharks—shows that we have
“barely scratched the surface of viral diversity”. Using
metatranscriptomics, Holmes’ team demonstrated ex-
ceptional levels of virus diversity and revealed the dy-
namic nature of viral genome size and organization. A
novel approach for viral discovery, using small interfer-
ing RNA (siRNA) as a marker of host response, was pre-
sented by Darren Obbard (University of Edinburgh, UK).
Uncharacterized or underappreciated viral diversity is
equally apparent at smaller taxonomic scales, as illus-
trated by the discovery of new viruses related to human
hepatitis A virus (Jan Felix Drexler, University of Bonn
Medical Centre, Germany) and by the re-emergence of
human noroviruses from unsampled reservoir popula-
tions (Chris Ruis, University College London, UK).Public health diagnostics and surveillance
Perhaps the strongest theme of the meeting was the use
of viral sequencing for surveillance and diagnostics in
public health. The surge of interest in this area is no
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eral talks. Kristian Anderson (The Scripps Research
Institute, La Jolla, USA) explained how the Broad
Institute’s Lassa Fever genomics infrastructure in Sierra
Leone was quickly repurposed for Ebola virus sequen-
cing and gave examples of epidemiological insights
drawn from genomics during the outbreak. He cautioned
that real-time genomics must lead to real-time action.
Specifically, he reported that genomic data could have
influenced public health conversations early in the out-
break; sequencing indicated that ongoing EBOV trans-
mission was not due to multiple spillovers from an
animal reservoir, yet messages about bushmeat con-
sumption probably gave the opposite impression. The
work presented by Kristian also demonstrated the utility
of clinical metagenomics in an outbreak, revealing the
associations between co-infection with malaria and
Ebola mortality. Gustavo Palacios (US Army Medical
Research Institute of Infectious Diseases (USAMRIID),
Frederick, MD) described EBOV genomics in Liberia,
where sequencing revealed the roles played by viral per-
sistence in immune-privileged sites in transmission from
survivors as the outbreak waned.
A glimpse of the future of surveillance was afforded by
Gytis Dudas’ (Fred Hutchinson Cancer Research Center,
Seattle, USA) meta-analysis of around 1600 EBOV
genomes sequenced across the two-year outbreak. His
phylogeographic analysis showed how EBOV lineages
crossed from one country to another, avoided extinction
by spreading within countries, and were magnified in
urban areas. Access to a subset of these data during the
outbreak resulted in border closures that limited the
epidemic, demonstrating that genomic information, ac-
quired in real time, could help to contain future epi-
demics. Ian Goodfellow (University of Cambridge, UK)
set up an EBOV sequencing center in Sierra Leone and
described how the attendant logistical challenges of such
a project, from sourcing nitrogen canisters to managing
samples, must not be underestimated. Ian demonstrated
the benefits of sharing, whether it be of open-access data
via platforms like virological.org and nextflu.org or of
the sequencing equipment itself, which was eventually
rehomed at the University of Makeni. Hinting at a
subject that might feature at the next edition of the con-
ference, Oliver Pybus (University of Oxford, UK) intro-
duced the ZiBRA project, which is using portable
nanopore sequencing in the field in Brazil to explore the
dynamics of the Zika virus epidemic.
From transmission to epidemics
The use of viral genomics as a tool to characterize trans-
mission is not restricted to emerging epidemics, having
been applied widely to established human pathogens. Ex-
amples presented at the meeting included reconstructionof a measles virus outbreak in Canada (Jennifer Gardy,
University of British Columbia, Canada), community
transmission of respiratory syncytial virus in Kenya
(Charles Agoti, KEMRI-Wellcome Trust, Kenya), hospital
outbreaks that were sequenced for infection control
as part of the ICONIC (InfeCtion respONse through
vIrus genomiCs) project (Paul Kellam, Sanger Institute,
Hinxton, UK), and the use of HIV and hepatitis C virus
(HCV) phylogenies to establish or disprove criminal trans-
mission in court (Annemie Vandamme, KU Leuven,
Belgium). Annemie explained why inferring the direction
of transmission is not equivalent to inferring direct trans-
mission and, through a series of real-world examples, she
established the conditions that must be met to argue for
transmission.
At a larger epidemic scale, Marion Koopmans
(Erasmus Medical Centre, The Netherlands) discussed
global norovirus dynamics as captured by the Noronet
surveillance platform, including the recent emergence of
recombinant strains that are undergoing rapid diversifi-
cation and the association of excess mortality with
new variants. Talks from Philippe Lemey (KU Leuven,
Belgium) and Kirstyn Brunker (University of Glasgow,
UK) demonstrated how other data sources can be
merged with viral genomes to help us to understand
epidemic dynamics, with examples showing how pre-
dictors such as spatial distance and case counts af-
fected the Ebola outbreak, and how human-mediated
connectivity and spatial heterogeneity influence rabies
virus transmission in Tanzania.
Antiviral treatment
The meeting also reflected a growing area of research in
which virus genomics is used to guide the design of ef-
fective antiviral drug interventions. Despite the approval
of new—but expensive—direct-acting antiviral drugs for
HCV infection, we still do not know what determines
whether treatment will be successful against the diverse
range of HCV genotypes. As Ellie Barnes and M. Azim
Ansari (University of Oxford, UK) explained, large-scale
sequencing of both HCV and human genomes, followed
by genome-wide association studies (GWAS), is begin-
ning to tease apart the host and virus genetic compo-
nents of treatment response.
Sequencing can also be used to observe the effects
of drugs on viral genomes directly. Daniel Goldhill
(Imperial College London, UK) showed evidence sup-
porting the hypothesis that the experimental com-
pound favipiravir acts to increase the mutation rate of
influenza A viruses. Viral genomics is also being used
to plan and evaluate large-scale treatment programs.
In the final keynote address, Christophe Fraser (Imperial
College London, UK) showed how viral phylogenetics is
being used to identify the source of new HIV infections in
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and treatment, which involves around 1.2 million people
in sub-Saharan Africa. He described how the huge scale of
such a project requires the development of new, efficient
methods of evolutionary analysis, as well as rigorous
thinking around sample size and power calculations for
tests based on phylogenetic and molecular clock models.
Evolutionary insights into pathogenesis
The importance of virus and host co-evolution was ap-
preciated by the audience. Sunetra Gupta’s (University of
Oxford, UK) dynamic models of the adaptive immune
system indicated that decreasing levels of CD4+ T cells
determined HIV viral loads during the chronic phase of
infection, which, in turn, determined the speed of dis-
ease progression. Sarah Cobey (University of Chicago,
USA) showed how influenza vaccines influence muta-
tions in host B cells, and Andrea Tanzer (University of
Vienna, Austria) asked whether, since Zika virus has been
circulating for decades, there are any genetic changes that
sparked the current outbreak in the Americas? By com-
paring the structure and folding kinetics of flaviviral RNA
elements involved in host response and virulence, she
identified specific mutations leading to RNA structural
alterations and evidence for selective pressure by compen-
satory mutations.
Concluding remarks
Although the conference focused on genomics and
evolution—topics that might be considered more theor-
etical than applied—it was notable that many speakers
talked as much about real people, some of whom have
suffered or died from viral disease, as they did about
data, theories, and technology. The frequency and scale
of viral outbreaks in recent years has emphasized the ur-
gency of research in virus genomics. Further, it has
prompted efforts to shift academic culture towards
closer collaborations between clinicians, biologists,
mathematicians, and computer scientists and towards
the real-time, open release and analysis of data, with the
shared aim of securing the health of our world’s popula-
tion. The next meeting is provisionally scheduled for
June 2018.
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